ClinicalTrials.Veeva

Menu

Social Prescribing and Relationship Cognitive Strategies (SPARCS)

University of Michigan logo

University of Michigan

Status

Active, not recruiting

Conditions

Suicidal Ideation
Social Isolation

Treatments

Other: Enhanced Usual Care
Behavioral: Social Prescribing
Behavioral: Brief Cognitive Therapy

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06656975
5R34MH132808-02 (U.S. NIH Grant/Contract)
HUM00258121

Details and patient eligibility

About

The study team is testing the acceptability and feasibility of two treatments for improving loneliness: Social Prescribing and Brief Cognitive Therapy.

For this pilot study, the study team have adapted these treatments for Collaborative Care and are studying whether these are practical and well-received by patients that might use them.

Full description

The study will take place at 2 University of Michigan sites.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Screen positive for either or both of the following during routine clinic screening:

    • Social isolation in the past 6 months, according to the screening question "How often do you feel isolated from others?"
    • Suicidal ideation in the past 12 months, according to the 9th item of the Patient Health Questionnaire (HQ-9) (per protocol)
  • Loneliness, according to the 3-item version of the University of California, Los Angeles (UCLA) Loneliness Scale (per protocol)

  • Are currently receiving or are able to initiate Collaborative Care Management at to participant's study site

Exclusion criteria

  • Currently receiving or have an active referral for specialty mental health or substance use disorder treatment outside of primary care
  • Neurocognitively impaired according to chart diagnosis, self-report on the Eligibility Screening Survey, or inability to answer comprehension check questions during the Informed Consent process (per protocol)
  • Unable to participate in the interventions and research assessments due to planned travel or limited phone access (e.g., does not own phone)
  • Terminally ill or receiving of palliative care with less than 6 months life expectancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 3 patient groups

Enhanced Usual Care control group
Other group
Description:
Participants will receive an informational booklet on improving loneliness and may initiate or continue Collaborative Care for other conditions on a not research basis. Besides the baseline survey participants will also take 2 more surveys, 3-months and 6-months from the first survey. Those surveys will ask similar questions and will take about 45 minutes to complete. These can be done online or over the phone with a researcher that will not know the treatment arm assignment.
Treatment:
Other: Enhanced Usual Care
Brief Cognitive Therapy then Social Prescribing
Experimental group
Description:
Besides the baseline survey participants will also take 2 more surveys, 3-months and 6-months from the first survey. Those surveys will ask similar questions and will take about 45 minutes to complete. These can be done online or over the phone with a researcher that will not know the treatment arm assignment.
Treatment:
Behavioral: Brief Cognitive Therapy
Behavioral: Social Prescribing
Social Prescribing then Brief Cognitive Therapy
Experimental group
Description:
Besides the baseline survey participants will also take 2 more surveys, 3-months and 6-months from the first survey. Those surveys will ask similar questions and will take about 45 minutes to complete. These can be done online or over the phone with a researcher that will not know the treatment arm assignment.
Treatment:
Behavioral: Brief Cognitive Therapy
Behavioral: Social Prescribing

Trial contacts and locations

2

Loading...

Central trial contact

Jennifer Jagusch; Paul Pfeiffer, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems